See more : Skylight Health Group Inc. (SLHG.V) Income Statement Analysis – Financial Results
Complete financial analysis of K+S Aktiengesellschaft (KPLUY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of K+S Aktiengesellschaft, a leading company in the Chemicals industry within the Basic Materials sector.
You may be interested
- Iguatemi S.A. (IGTI3.SA) Income Statement Analysis – Financial Results
- ShaMaran Petroleum Corp. (SNM.V) Income Statement Analysis – Financial Results
- Silgan Holdings Inc. (SLGN) Income Statement Analysis – Financial Results
- PQ Group Holdings Inc. (PQG) Income Statement Analysis – Financial Results
- Cytori Cell Research Institute, Inc. (3750.T) Income Statement Analysis – Financial Results
K+S Aktiengesellschaft (KPLUY)
About K+S Aktiengesellschaft
K+S Aktiengesellschaft, together with its subsidiaries, operates as a supplier of mineral products for the agricultural, industrial, consumer, and community segments worldwide. It operates through Agriculture, and Industry+ segments. The Agriculture segment offers potassium chloride for important crops, such as cereals, corn, rice, and soybeans; and fertilizer specialties that are used for crops for magnesium and sulfur, including rapeseed or potatoes, as well as for chloride-sensitive crops consisting of citrus fruits, grapes, or vegetables. The segment markets under the product brands, including KALISOP, KORN-KALI, PATENTKALI, ESTA KIESERIT, MAGNESIA-KAINIT, SOLUMOP, SOLUSOP, SOLUNOP, SOLUMAP, SOLUMKP, EPSO TOP, EPSO MICROTOP, EPSO COMBITOP, EPSO PROFITOP, and EPSO BORTOP. The Industry+ segment provides potash, magnesium, and salt products for industrial applications that are available in different degrees of purity and in specific grain sizes under the brands comprising APISAL, AXAL, BÄCKERSTOLZ, KASA, k-DRILL, NUTRIKS, and SOLSEL. The company was founded in 1889 and is based in Kassel, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.87B | 5.68B | 3.21B | 2.43B | 4.07B | 4.04B | 3.63B | 3.46B | 4.18B | 3.82B | 3.95B | 3.94B | 5.15B | 4.99B | 3.57B | 4.79B | 3.34B | 2.96B | 2.82B | 2.58B | 2.29B | 2.26B | 2.18B | 2.09B | 2.33B | 2.23B |
| Cost of Revenue | 3.31B | 3.22B | 734.00M | 4.16B | 3.37B | 2.78B | 2.41B | 2.11B | 2.26B | 2.21B | 2.25B | 2.16B | 3.18B | 3.08B | 2.34B | 2.55B | 2.21B | 1.91B | 1.81B | 1.71B | 1.54B | 1.51B | 1.47B | 1.42B | 1.43B | 1.41B |
| Gross Profit | 563.80M | 2.46B | 2.48B | -1.73B | 698.10M | 1.26B | 1.21B | 1.35B | 1.92B | 1.61B | 1.70B | 1.78B | 1.97B | 1.92B | 1.23B | 2.24B | 1.13B | 1.04B | 1.00B | 876.54M | 748.14M | 745.80M | 704.62M | 670.07M | 900.33M | 822.17M |
| Gross Profit Ratio | 14.56% | 43.29% | 77.16% | -71.00% | 17.15% | 31.19% | 33.43% | 38.94% | 45.86% | 42.15% | 43.15% | 45.15% | 38.34% | 38.41% | 34.41% | 46.75% | 33.85% | 35.29% | 35.68% | 33.95% | 32.70% | 33.02% | 32.33% | 32.09% | 38.62% | 36.90% |
| Research & Development | 12.40M | 11.60M | 10.00M | 11.10M | 16.00M | 15.90M | 16.60M | 13.70M | 14.70M | 12.20M | 13.90M | 19.40M | 17.80M | 15.50M | 18.72M | 18.07M | 15.52M | 13.80M | 13.00M | 12.84M | 13.16M | 13.23M | 13.64M | 14.83M | 16.14M | 14.27M |
| General & Administrative | 120.00M | 125.80M | 1.10M | 9.10M | 29.30M | 252.30M | 231.40M | 227.30M | 234.70M | 202.00M | 199.50M | 197.40M | 182.10M | 183.60M | 123.06M | 104.36M | 89.38M | 82.08M | 71.65M | 64.08M | -56.46M | -53.29M | -54.84M | 34.21M | 50.48M | 49.49M |
| Selling & Marketing | 63.50M | 61.00M | 175.90M | 197.10M | 362.80M | 779.80M | 704.50M | 737.10M | 824.50M | 796.20M | 835.60M | 734.20M | 843.60M | 971.90M | 712.46M | 775.99M | 752.34M | 728.12M | 673.04M | 623.72M | 554.93M | 546.50M | 527.86M | 495.05M | 620.15M | 591.18M |
| SG&A | 183.50M | 186.80M | 177.00M | 206.20M | 392.10M | 1.03B | 935.90M | 964.40M | 1.06B | 998.20M | 1.04B | 931.60M | 1.03B | 1.16B | 835.51M | 880.35M | 841.72M | 810.20M | 744.69M | 687.80M | 498.46M | 493.21M | 473.02M | 529.26M | 670.62M | 640.67M |
| Other Expenses | 42.90M | 45.80M | 21.70M | -15.30M | 8.80M | -18.40M | -12.10M | -11.60M | -8.20M | -11.90M | -6.80M | -13.70M | -19.80M | 15.70M | -35.95M | -150.37M | -392.62M | -56.44M | 5.03M | 8.79M | -205.00K | -37.85M | -5.15M | 3.64M | 40.51M | 17.73M |
| Operating Expenses | 238.80M | 244.20M | 208.70M | 202.00M | 416.90M | 1.01B | 934.70M | 1.03B | 1.06B | 952.20M | 1.03B | 907.70M | 1.02B | 1.19B | 953.00M | 898.87M | 846.42M | 767.56M | 762.72M | 709.42M | 632.46M | 613.02M | 584.02M | 549.53M | 727.28M | 680.77M |
| Cost & Expenses | 3.55B | 3.46B | 942.70M | 4.36B | 3.79B | 3.79B | 3.35B | 3.14B | 3.32B | 3.16B | 3.28B | 3.07B | 4.20B | 4.26B | 3.30B | 3.45B | 3.06B | 2.68B | 2.57B | 2.41B | 2.17B | 2.13B | 2.06B | 1.97B | 2.16B | 2.09B |
| Interest Income | 23.60M | 103.40M | 73.50M | 8.60M | 9.20M | 11.60M | 10.60M | 6.50M | 10.00M | 24.10M | 24.00M | 21.20M | 13.10M | 7.60M | 4.65M | 25.06M | 6.69M | 7.38M | 5.67M | 5.46M | 0.00 | 0.00 | 0.00 | 6.27M | 8.73M | 0.00 |
| Interest Expense | 54.70M | 28.30M | 87.20M | 100.00M | 144.20M | 120.70M | 53.40M | 54.70M | 52.50M | 152.90M | 99.80M | 106.70M | 78.00M | 134.20M | 61.71M | 29.65M | 35.57M | 27.52M | 17.76M | 5.66M | 3.85M | 2.36M | 733.00K | 6.27M | 0.00 | 0.00 |
| Depreciation & Amortization | 455.80M | 449.70M | 333.40M | 352.30M | 463.40M | 410.00M | 316.00M | 326.20M | 8.30M | 8.30M | 11.50M | 4.10M | 242.00M | 248.30M | -88.76M | 141.71M | 128.21M | 123.31M | 132.17M | 115.18M | 108.79M | -36.69M | 128.75M | -6.27M | 0.00 | 0.00 |
| EBITDA | 807.50M | 2.73B | 2.33B | 374.90M | 549.60M | 623.10M | 576.50M | 583.60M | 742.70M | 695.80M | 660.10M | 872.90M | 905.70M | 968.90M | 362.00M | 1.37B | 27.89M | 492.29M | 409.52M | 284.17M | 224.26M | 224.18M | 245.03M | 242.51M | 173.06M | 141.40M |
| EBITDA Ratio | 20.85% | 48.15% | 72.61% | 13.08% | 17.22% | 15.43% | 15.89% | 9.22% | 21.17% | 18.09% | 17.85% | 22.61% | 23.44% | 19.83% | 5.26% | 28.58% | 0.63% | 16.64% | 14.54% | 11.01% | 9.80% | 4.25% | 11.24% | 5.77% | 7.42% | 6.35% |
| Operating Income | 325.00M | 2.29B | 3.85B | -1.95B | 268.90M | 227.20M | 270.80M | 229.30M | 781.60M | 641.30M | 655.90M | 808.50M | 951.20M | 731.50M | 276.91M | 1.34B | 285.70M | 278.04M | 250.89M | 163.11M | 115.68M | 132.77M | 120.60M | 126.80M | 173.06M | 141.40M |
| Operating Income Ratio | 8.39% | 40.34% | 119.87% | -80.20% | 6.61% | 5.63% | 7.47% | 6.63% | 18.72% | 16.78% | 16.60% | 20.54% | 18.47% | 14.65% | 7.75% | 28.01% | 8.54% | 9.40% | 8.91% | 6.32% | 5.06% | 5.88% | 5.53% | 6.07% | 7.42% | 6.35% |
| Total Other Income/Expenses | -28.00M | -35.90M | 57.10M | -70.30M | -80.70M | -112.20M | -26.40M | 9.80M | -170.30M | -126.10M | -108.90M | -40.90M | -87.60M | -132.40M | -115.46M | -136.57M | -428.29M | 63.42M | 8.70M | -39.51M | -4.05M | -39.04M | -5.06M | -17.69M | 7.39M | 18.59M |
| Income Before Tax | 297.00M | 2.13B | 2.43B | -2.00B | 127.00M | 53.10M | 300.90M | 239.10M | 681.90M | 534.60M | 548.80M | 766.90M | 887.30M | 608.00M | 126.44M | 1.20B | -142.58M | 341.46M | 259.60M | 163.11M | 111.63M | 93.73M | 115.54M | 130.44M | 187.51M | 159.99M |
| Income Before Tax Ratio | 7.67% | 37.61% | 75.50% | -82.20% | 3.12% | 1.31% | 8.30% | 6.92% | 16.33% | 13.99% | 13.89% | 19.49% | 17.23% | 12.18% | 3.54% | 25.01% | -4.26% | 11.54% | 9.22% | 6.32% | 4.88% | 4.15% | 5.30% | 6.25% | 8.04% | 7.18% |
| Income Tax Expense | 87.10M | 626.40M | 252.80M | -108.20M | 38.10M | 10.90M | 116.30M | 64.70M | 186.50M | 153.40M | 133.20M | 198.40M | 230.70M | 158.60M | -29.57M | 327.69M | -49.47M | 70.30M | 85.15M | 22.57M | -10.33M | -10.07M | -2.78M | -10.66M | -5.19M | -3.57M |
| Net Income | 210.20M | 1.51B | 2.17B | -1.89B | 88.90M | 42.10M | 184.60M | 174.10M | 495.20M | 380.50M | 412.80M | 665.30M | 564.30M | 448.60M | 96.40M | 870.89M | -93.34M | 270.79M | 174.45M | 140.54M | 101.30M | 103.80M | 118.32M | 119.78M | 192.70M | 163.56M |
| Net Income Ratio | 5.43% | 26.57% | 67.63% | -77.75% | 2.18% | 1.04% | 5.09% | 5.04% | 11.86% | 9.96% | 10.45% | 16.91% | 10.96% | 8.98% | 2.70% | 18.16% | -2.79% | 9.16% | 6.20% | 5.44% | 4.43% | 4.60% | 5.43% | 5.74% | 8.27% | 7.34% |
| EPS | 1.12 | 7.88 | 11.35 | -9.88 | 0.46 | 0.11 | 0.48 | 0.46 | 1.30 | 1.00 | 1.08 | 1.74 | 1.48 | 1.17 | 0.29 | 2.64 | -0.27 | 0.78 | 0.49 | 0.39 | 0.29 | 0.29 | 0.19 | 0.23 | 0.31 | 0.31 |
| EPS Diluted | 1.12 | 7.88 | 11.35 | -9.88 | 0.46 | 0.11 | 0.48 | 0.46 | 1.30 | 1.00 | 1.08 | 1.74 | 1.48 | 1.17 | 0.29 | 2.64 | -0.27 | 0.78 | 0.49 | 0.39 | 0.29 | 0.29 | 0.19 | 0.23 | 0.31 | 0.31 |
| Weighted Avg Shares Out | 187.30M | 191.40M | 191.40M | 191.40M | 191.40M | 382.80M | 382.80M | 382.80M | 382.80M | 382.80M | 382.80M | 382.80M | 382.66M | 382.68M | 332.30M | 329.88M | 347.96M | 348.01M | 357.04M | 358.64M | 352.73M | 361.17M | 616.33M | 510.48M | 629.87M | 534.97M |
| Weighted Avg Shares Out (Dil) | 187.30M | 191.40M | 191.40M | 191.40M | 191.40M | 382.80M | 382.80M | 382.80M | 382.80M | 382.80M | 382.80M | 382.80M | 382.66M | 382.68M | 332.30M | 329.88M | 347.96M | 348.01M | 357.04M | 358.64M | 352.73M | 361.17M | 616.33M | 510.48M | 629.87M | 534.97M |
K+S: Fertilizer Will Come Back Eventually, And I Am 'In'
K+S remains a solid investment due to its diversified business in potash and salt, despite recent market volatility and sector challenges. The company's fundamentals are strong, with significant revenue and EBITDA, and it benefits from geopolitical trends affecting potash supply...
K+S: Bottom Reached, I Believe We're Moving Upward From Here
K+S, a fertilizer and salt company, has seen a decline in its overall fortunes and earnings. Despite the decline, the company is still considered a solid investment with potential upside. The company's fundamentals are strong, with impressive revenues and a...
K+S: I See The Bottom, But I'm Cutting My Price Target.
K+S, a fertilizer and salt company, has experienced a decline in earnings due to a contraction in the fertilizer market. The company's annual expected EBITDA is significantly lower than previous years, but sales volumes are expected to remain stable. Despite...
K+S Aktiengesellschaft (KPLUY) Q3 2023 Earnings Call Transcript
K+S Aktiengesellschaft (OTCQX:KPLUY) Q3 2023 Earnings Conference Call November 14, 2023 4:00 AM ET Company Participants Julia Bock - Head, IR Burkhard Lohr - CEO Christian Meyer - CFO Conference Call Participants Alexander Jones - Bank of America Christian Faitz...
K+S Aktiengesellschaft (KPLUY) Q2 2023 Earnings Call Transcript
K+S Aktiengesellschaft (OTCQX:KPLUY) Q2 2023 Earnings Conference Call August 10, 2023 4:00 AM ET Company Participants Julia Bock – Head of Investor Relations Burkhard Lohr – Chief Executive Officer Christian Meyer – Chief Financial Officer Conference Call Participants Markus Mayer...
K+S Aktiengesellschaft: Yet More Upside To Be Had Due To Tightening Spreads
K+S, a leading fertilizer and salt company, has seen strong financial performance with gross margins above 42% and net margins over 25.8%. The company has minor debt and hasn't issued new shares for over 10 years. The company is expected...
Munich Re Shines, Fraport Stagnates, K+S Drops: Reviewing My German Stocks After A Year
It's time to review my investments in three German stocks: Munich Re, Fraport, and K+S. Munich Re performed exceptionally well, Fraport showed average performance, and K+S dropped by 30%. I discuss my expectations for these stocks for the rest of...
K+S Aktiengesellschaft (KPLUY) Q1 2023 Earnings Call Transcript
Start Time: 04:00 January 1, 0000 4:26 AM ET K+S Aktiengesellschaft (OTCQX:KPLUY) Q1 2023 Earnings Conference Call May 09, 2023, 04:00 AM ET Company Participants Burkhard Lohr - CEO Christian Meyer - CFO Julia Bock - IR Conference Call Participants...
K+S Aktiengesellschaft: After A Drop, There Is Upside To Be Had Here
I've been covering K+S for about a year at this point and would consider my position in the company a long-term one. While macro has changed somewhat since my last piece back in February, the company remains an attractive prospect...
K+S Aktiengesellschaft (KPLUY) Q4 2022 Earnings Call Transcript
K+S Aktiengesellschaft (OTCQX:KPLUY) Q4 2022 Results Conference Call March 15, 2023 5:00 AM ET Company Participants Julia Bock - Investor Relations Burkhard Lohr - Chief Executive Officer Christian Meyer - Chief Financial Officer Conference Call Participants Markus Mayer - Baader-Helvea...
Source: https://incomestatements.info
Category: Stock Reports